Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1461 (LINC01461) is a human long intergenic non-coding RNA (lincRNA) that belongs to the subclass of lncRNAs transcribed from intergenic regions, typically longer than 200 nucleotides, and not overlapping protein-coding genes[1][5]. LincRNAs such as LINC01461 are implicated in key processes including chromatin remodeling, regulation of gene expression, and transcriptional modulation, often with high tissue specificity. However, the specific biological functions, disease associations, and potential as a therapeutic target for LINC01461 remain undetermined, and there is no evidence supporting its role as a drug target or clinical biomarker at this time[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1461 (LINC01461).